Bacil Pharma stake cut to 10.02% via open market sales
Manubhai Amrutlal Shah reduced his shareholding in Bacil Pharma Limited by disposing of 3,94,893 equity shares through open market transactions on June 23 and June 24, 2026. The sales, conducted under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, lowered his stake from 12.77% to 10.02% of the total voting capital.
*this image is generated using AI for illustrative purposes only.
Manubhai Amrutlal Shah has reduced his shareholding in Bacil Pharma Limited following the disposal of 3,94,893 equity shares through open market transactions on June 23 and June 24, 2026. The disclosure, submitted to the Bombay Stock Exchange under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, details the shift in ownership structure.
The transactions reduced Shah's total holding from 18,31,709 shares to 14,36,816 shares. Consequently, his ownership percentage decreased from 12.77% to 10.02% of the company's total voting capital. The equity share capital of Bacil Pharma Limited remains unchanged at 1,43,53,000 equity shares of ₹10 each.
Shareholding Details
The following table outlines the changes in Manubhai Amrutlal Shah's shareholding in Bacil Pharma Limited:
| Particulars | Number of Shares | % of Total Share/Voting Capital | % of Total Diluted Share/Voting Capital |
|---|---|---|---|
| Before Disposal | |||
| Shares carrying voting rights | 18,31,709 | 12.77% | 12.77% |
| Disposal | |||
| Shares sold | 3,94,893 | 2.75% | 2.75% |
| After Disposal | |||
| Shares carrying voting rights | 14,36,816 | 10.02% | 10.02% |
The acquirer clarified that he does not belong to the promoter or promoter group of the target company. The total diluted share and voting capital of Bacil Pharma Limited remains unavailable as per the filing.
Historical Stock Returns for Bacil Pharma
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.52% | +0.38% | -18.15% | +4.04% | +6.17% | +470.82% |
What motivated the shareholder to reduce his stake just below the 10% threshold?
Who were the primary buyers of these shares, and does this indicate a change in institutional investor interest?
How might this reduction in holding by a significant non-promoter investor impact Bacil Pharma's stock liquidity?
16
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
